
DNTH
USDDianthus Therapeutics Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$33.890
High
$34.110
Low
$32.960
Volume
0.43M
Company Fundamentals
Market Cap
1.3B
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.69M
Exchange
NCM
Currency
USD
52-Week Range
Related News
Dianthus Therapeutics Highlights New Claseprubart Data Presented During 2025 AANEM Annual Meeting
Positive data from Phase 2 MaGic trial presented for claseprubart in generalized Myasthenia Gravis, including new open-label extension data further supporting potential for 300mg/2mL Q4W dosing Phase 3 gMG trial planned
Truist Securities Initiates Coverage On Dianthus Therapeutics with Buy Rating, Announces Price Target of $56
Truist Securities analyst Danielle Brill initiates coverage on Dianthus Therapeutics with a Buy rating and announces Price Target of $56.
Related Stocks
RGC
Regencell Bioscience Holdings Limited Ordinary Shares
SOJE
Southern Company (The) Series 2020C 4.20% Junior Subordinated Notes due October 15 2060
LFUS
Littelfuse Inc.
CBH
Virtus Convertible & Income 2024 Target Term Fund Common Shares of Beneficial Interest
SMC
Summit Midstream Corporation
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.